Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle

Circulation

Volumn 93, Issue 4, 1996, Pages 720-729

  Lewis, Neil P ^a,d   Tsao, Philip S ^a   Rickenbacher, Peter R ^a   Xue, Chun ^c   Johns, Roger A ^c   Haywood, Guy A ^a   Von Der Leyen, Heiko ^a   Trindade, Pedro T ^a   Cooke, John P ^a   Hunt, Sharon A ^a   Billingham, Margaret E ^b   Valantine, Hannah A ^a   Fowler, Michael B ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

heart failure; nitric oxide; rejection; transplantation

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ADULT; ARTICLE; CLINICAL ARTICLE; ENZYME INDUCTION; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE PERFORMANCE; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

EID: 9044223657     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.4.720     Document Type: Article

References (47)

1. The Registry of the International Society for Heart and Lung Transplantation: Tenth Official Report. J Heart Lung Transplant. 1993;12:543-548.
2. Barry WH. Mechanisms of immune-mediated myocyte injury. Circulation. 1994;89:2421-2432.
3. Valantine HA. Rejection surveillance by Doppler echocardiography. J Heart Lung Transplant. 1993;12:422-426.
4. Stevenson LW, Lewis W, McAlpin WR, Clark S. Acute reversible cardiogenic shock: immune-mediated with mild histologic change. Am Heart J. 1986;111:611-613.
5. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Physiol Rev. 1991;43:109-142.
6. Cooke JP, Rossitch E Jr, Andon NA, Loscalzo J, Dzau VJ. Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. J Clin Invest. 1991;88:1663-1671.
7. Knowles RG, Merrett M, Salter M, Moncada S. Differential induction of brain, lung and liver nitric oxide synthase by endotoxin in the rat. Biochem J. 1990;270:833-836.
8. 2+-independent nitric oxide synthases. FEBS Lett. 1991;291: 145-149.
9. Nava E, Palmer RJM, Moncada S. Inhibition of nitric oxide synthesis in septic shock: how much is beneficial? Lancet. 1991;338: 1555-1557.
10. Petros A, Bennett D, Valance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet. 1991;338:1557-1558.
11. G-monomethyl-L-arginine. J Cardiovasc Pharmacol. 1992;20(suppl):S132-S134.
12. Balligand JL, Ungureanu D, Kelly RA, Kobzik L, Pimental D, Michel T, Smith T. Abnormal contractile function due to induction of nitric oxide synthase in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest. 1993;91: 2314-2319.
13. Finkel MS, Odis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 1992;257:387-389.
14. Brady AJB, Warren JB, Poole-Wilson PA, Williams TJ, Harding SE. Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol. 1993;265:H176-H182.
15. Brady AJB, Poole-Wilson PA, Harding SE, Warren JB. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol. 1992;263:H1963-H1966.
16. 2+-independent nitric oxide synthase in the myocardium. Br J Pharmacol. 1992;105:575-580.
17. Suffredini AF, Fromm RF, Parker MM, Brenner M, Kovacs JA, Wesley RA, Parrillo JE. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med. 1989;321: 280-287.
18. Abel FL. Does the heart fail in endotoxin shock? Circ Shock. 1990; 30:5-13.
19. Dayton LR, Walker RE, Kovacs JA, Herpin B, Parker M, Masur H, Fauci AS, Lane HC. Reversible cardiac dysfunction associated with interferon alfa therapy in AIDS patients with Kaposi's sarcoma. N Engl J Med. 1989;321:1246-1249.
20. Nora R, Abrams JS, Tait NS, Hiponia DJ, Silverman HJ. Myocardial toxic effects during recombinant interleukin-2 therapy. J Natl Cancer Inst. 1989;81:59-63.
21. Wu CJ, Lovett M, Wong-Lee J, Moeller F, Kitamura M, Goralski TJ, Billingham ME, Starnes VA, Clayberger C. Cytokine gene expression in rejecting cardiac allografts. Transplantation. 1992;54: 326-332.
22. Cunningham DA, Dunn MJ, Yacoub MH, Rose ML. Local production of cytokines in the human cardiac allograft. Transplantation. 1994;57:1333-1337.
23. 2+]; and cell contraction in cultured chick ventricular myocytes. Circ Res. 1994;75:285-295.
24. Roberts AB, Vodouotz Y, Roche NS, Sporn MB, Nathan FC. Role of nitric oxide in antagonistic effects of transforming growth factor β and interleukin-1 β on the beating rate of cultured cardiac myocytes. Mol Endocrinol. 1992;6:1921-1930.
25. Balligand JL, Ungureanu D, Pimental D, Kelly RA, Smith TW, Michel T. Detection of transcripts for a cytokine-inducible nitric oxide synthase isoform in adult rat ventricular myocytes. Circulation. 1993;88(pt 2):II-1-II-384.
26. Yang X, Chowhury N, Cai B, Marboe S, Sciacca RR, Michler RE, Cannon PJ. Induction of myocardial nitric oxide synthase by cardiac allograft rejection. J Clin Invest. 1994;94:714-721.
27. Lancaster JR, Langrehr JM, Bergonia HA, Murase N, Simmons RL, Hoffman RA. EPR detection of heme and nonheme iron- containing protein nitrosylation by nitric oxide during rejection of the rat heart allograft. J Biol Chem. 1992;267:10994-10998.
28. Langrehr JM, Murase N, Markus PM, Cai X, Neuhaus P, Schraut W, Simmons RL, Hoffman RA. Nitric oxide production in host- versus-graft and graft-versus-host reactions in the rat. J Clin Invest. 1992;90:679-683.
29. Billingham ME, Carey NRB, Hammond ME, Kemnitz J, Marboe C, McAllister HA. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. J Heart Lung Transplant. 1990;9:587-592.
30. Chomozynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium-thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
31. Shi Y, Hutchinson H, Hall DJ, Zalewski A. Downregulation of c-myc expression by antisense oligonucleotides inhibits proliferation of human smooth muscle cells. Circulation. 1993;88: 1190-1195.
32. Geller DA, Lowenstein CJ, Shapiro RA, Nussler AK, Di Silvio M, Wang SC, Nakayama DK, Simmons RL, Snyder SH, Billiar TR. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci USA. 1993;90: 3491-3495.
33. Charles IG, Palmer RMJ, Hickery MS, Bayliss MT, Chubb AP, Hall VS, Moss DW, Moncada S. Cloning, characterization and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte. Proc Natl Acad Sci U S A. 1993;90: 11419-11423.
34. Chartrain NA, Geller DA, Koty PP, Sitrin NF, Nussler AK, Hoffman EP, Billiar TR, Hutchinson NI, Mudgett JS. Molecular cloning, structure and chromosomal localization of the human inducible nitric oxide synthase gene. J Biol Chem. 1994;269: 6765-6772.
35. Tsao PS, McEvoy LM, Drexler H, Butcher EC, Cooke JP. Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine. Circulation. 1994;89:2176-2182.
36. Valantine HA, Appleton CP, Hatle LK, Hunt SA, Stinson EB, Popp RL. Influence of recipient atrial contraction on left ventricular filling dynamics on the transplanted heart assessed by Doppler echocardiography. Am J Cardiol. 1987;59:1159-1163.
37. Valantine HA, Appleton CP, Hatle LK, Hunt SA, Stinson EB, Popp RL. Variability of Doppler echocardiographic indices of left ventricular filling in transplant recipients and normal subjects. J Am Soc Echocardiogr. 1990;3:276-284.
38. Sherman PA, Laubach VE, Reep BR, Wood ER. Purification and cDNA sequence of an inducible nitric oxide synthase from a human tumor cell line. Biochemistry. 1993;32:11600-11605.
39. Paulus WJ, Vantrimpont PJ, Shah AM. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans: assessment by bicoronary sodium nitroprusside infusion. Circulation. 1994;89:2070-2078.
40. Shah AM, Mebazaa A, Wetzel RC, Lakatta EG. Novel cardiac myofilament desensitizing factor released by endocardial and vascular endothelial cells. Circulation. 1994;89:2492-2497.
41. De Belder A, Radomski M, Why H, Richardson P, Martin J, Moncada S. Expression of an inducible NO synthase in heart tissue from patients with inflammatory heart disease. J Am Coll Cardiol. 1994;(suppl):263A. Abstract.
42. Langrehr JM, Hoffman RA, Billiar TR, Lee KKW, Schraut WH, Simmons RL. Nitric oxide synthesis in the in vivo allograft response: a possible regulatory mechanism. Surgery. 1991;110: 335-342.
43. Griffiths GM, Namikawa R, Mueller C, Liu C, Young JD, Billingham ME, Weissman I. Granzyme A and perforin as markers for rejection in cardiac transplantation. Eur J Immunol. 1991;21: 687-692.
44. Miller LW, Wesp A, Jennison SH, Graham MA, Martin TW, McBride LR, Pennington DG, Peigh P. Vascular rejection in heart transplant recipients. J Heart Lung Transplant. 1993;12(pt 2): S147-S153.
45. Bonnaud EN, Lewis NP, Billingham ME. The reliability and usefulness of immunofluorescence in cardiac transplantation. J Heart Lung Transplant. 1995;14:163-171.
46. Gao SZ, Shroeder JS, Hunt SA, Valantine HA, Hill IR, Stinson EB. Influence of graft rejection on incidence of accelerated graft coronary artery disease: a new approach to analysis. J Heart Lung Transplant. 1993;12:1029-1035.
47. Hibbs JB, Westenfelder C, Taintor R, Vavrin Z, Kablitz C, Baranowski RL, Ward JH, Menlove RL, McMerry MP, Kushner JP, Baranowski WE. Evidence for cytokine-induced nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J Clin Invest. 1992;89:867-877.